Clinical Trial Update: A Pilot Study to Evaluate The Efficacy of Adapalene 0.3% for Use in the Prevention and Treatment of Senile Purpura [Phase 2]

View source ↗

Summary

A Phase 2 pilot study is evaluating the efficacy of adapalene 0.3% for prevention and treatment of senile purpura; the study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Senile Purpura

Drugs mentioned

• Adapalene 0.3% (adapalene)

Snippet

Sponsor: Multispecialty Aesthetic Clinical Research Organization | Conditions: Senile Purpura | Phase 2 | Status: UNKNOWN